v3.25.2
Net Loss per Share
6 Months Ended
Jun. 30, 2025
Earnings Per Share [Abstract]  
Net Loss per Share

Note 9. Net loss per share

Basic net loss per share is computed by dividing net loss by the weighted-average number of common stock outstanding during the period. Shares of common stock that are potentially issuable for little or no cash consideration at issuance, such as the Company's pre-funded warrants issued in October 2023 and in connection with the exercise of certain May 2023 Tranche A and Tranche B warrants, are considered outstanding common stock and are included in the calculation of basic and diluted net loss per share in connection with ASC 260 Earnings Per Shares. Diluted net loss per share is computed by dividing net loss by the weighted-average number of common stock outstanding and dilutive potential common stock that would be issued upon the exercise or vesting of common stock awards and exercise of common stock warrants that are not pre-funded. The Company applies the two-class method to calculate basic and diluted earnings per share as its warrants issued in March 2022, May 2023 and October 2023 are participating securities. However, the two-class method does not impact the net loss per share of common stock as the March 2022, May 2023 and October 2023 common warrants issued do not participate in losses. For the three and six months ended June 30, 2025 and 2024, the effect of issuing potential common stock is anti-dilutive due to the net losses in those periods and therefore the number of shares used to compute basic and diluted net loss per share are the same in each of those periods.

The following securities are the weighted-average common shares outstanding used to calculate basic and diluted net loss per common share:

 

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

Common stock

 

 

50,233,281

 

 

 

35,641,878

 

 

 

48,092,928

 

 

 

34,037,201

 

May 2023 Tranche A pre-funded warrants

 

 

-

 

 

 

2,241,352

 

 

 

-

 

 

 

2,325,091

 

May 2023 Tranche B pre-funded warrants

 

 

-

 

 

 

451,632

 

 

 

-

 

 

 

451,632

 

October 2023 pre-funded warrants

 

 

250,000

 

 

 

296,703

 

 

 

250,000

 

 

 

606,044

 

Total

 

 

50,483,281

 

 

 

38,631,565

 

 

 

48,342,928

 

 

 

37,419,968

 

 

The following potentially dilutive securities outstanding have been excluded from the computations of diluted weighted-average shares outstanding for the periods presented because such securities have an antidilutive impact due to losses reported (in common stock equivalent shares):

 

 

 

As of June 30,

 

 

 

2025

 

 

2024

 

Warrants issued to 2010/2012 convertible note
   holders to purchase common stock

 

 

-

 

 

 

6,804

 

Warrants issued to underwriter to purchase common stock

 

 

-

 

 

 

1,100

 

March 2022 common warrants

 

 

516,265

 

 

 

1,483,743

 

May 2023 Tranche B warrants

 

 

-

 

 

 

5,775,000

 

Options to purchase common stock

 

 

3,468,278

 

 

 

3,305,259

 

Outstanding restricted stock units

 

 

468,457

 

 

 

256,030

 

Total

 

 

4,453,000

 

 

 

10,827,936